{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T08:51:42Z","timestamp":1760345502308},"reference-count":0,"publisher":"American Psychological Association (APA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental and Clinical Psychopharmacology"],"published-print":{"date-parts":[[1997]]},"DOI":"10.1037\/\/1064-1297.5.3.216","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T04:11:37Z","timestamp":1027656697000},"page":"216-234","source":"Crossref","is-referenced-by-count":1,"title":["The expanding indications for clozapine."],"prefix":"10.1037","volume":"5","author":[{"given":"Carl R.","family":"Young","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James G.","family":"Longhurst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm B., Jr.","family":"Bowers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn M.","family":"Mazure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"15","container-title":["Experimental and Clinical Psychopharmacology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T19:58:08Z","timestamp":1428609488000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.apa.org\/getdoi.cfm?doi=10.1037\/1064-1297.5.3.216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1997]]}},"alternative-id":["1997-05212-005"],"URL":"https:\/\/doi.org\/10.1037\/\/1064-1297.5.3.216","relation":{},"ISSN":["1064-1297"],"issn-type":[{"value":"1064-1297","type":"print"}],"subject":[],"published":{"date-parts":[[1997]]}}}